3 Biotech Stocks to Buy in a Market Crash
Gilead Sciences, Celgene Corp, and Regeneron Pharmaceuticals are best-in-class in biotech.
Pfizer Gets Back to Growth
Guidance for 2016 suggests that a corner is turning for this industry Goliath.
Curing Hepatitis C: How Gilead Sciences Plans to Beat Merck
Merck's Zepatier poses a new challenge to Gilead's best-selling drug, but maybe it's not as threatening as some think.
1 Chart That's Bringing Big Smiles to America's Largest Companies
You might be witnessing a sea of red, but the recent retracement in this index could be a very good thing for America's largest companies.